Trilaciclib-d8 hydrochloride

SL-11776

Trilaciclib-d8 hydrochloride, >98%

Synonyms : G1T28-d8 hydrochloride

IUPAC Name : 2'-((5-(4-Methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyridin-2-yl)amino)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one hydrochloride

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Trilaciclib-d8 dihydrochloride is a deuterium-labelled version of Trilaciclib dihydrochloride. This can be used as an analytical labelled reference standard. Trilaciclib is an oral CDK4/6 inhibitor. It effectively suppresses tumour cell proliferation and helps reduce the blood-related toxicity associated with chemotherapy. Additionally, Trilaciclib dihydrochloride lessens both apoptosis and myelosuppression caused by 5-Fluorouracil (5-FU) chemotherapy.

References : Bisi J. E. et al.: Mol Cancer Ther., 15(5), 783-93, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.